PEAK6 Investments’s AtriCure ATRC Stock Holding History

PEAK6 Investments’s Portfolio ATRC Stock Details ATRC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q3	–	Sell	-15,731	Closed	-$707K	–	4344
2020 Q2	$707K	Buy	+15,731	New	+$685K	﹤0.01%	2399
2018 Q4	–	Sell	-15,967	Closed	-$559K	–	3982
2018 Q3	$559K	Buy	+15,967	New	+$506K	﹤0.01%	2475

Other funds holding ATRC

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

FAM

Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

CIP

Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return

TCM

TimesSquare Capital Management New York $5.89B AUM 28.74% 1-Year Est. Return

OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

PEAK6 Investments's ATRC Position: Q3 2020 in Review

PEAK6 Investments sold out of AtriCure (ATRC) in Q3 2020, closing a stake of 15,731 shares — an estimated $707K sold.

PEAK6 Investments first reported a position in ATRC in Q3 2018 and held it in 2 quarters. The position peaked at $707K in Q2 2020. 183 funds tracked by Wall St. Rank hold ATRC as of Q3 2020.

PEAK6 Investments reported no remaining AtriCure position as of Q3 2020 after selling out during the quarter.
PEAK6 Investments sold 15,731 AtriCure shares in Q3 2020, an estimated $707K.
PEAK6 Investments first reported a position in AtriCure in Q3 2018 and held it in 2 quarters.
PEAK6 Investments's AtriCure position peaked at $707K in Q2 2020.
183 funds tracked by Wall St. Rank held AtriCure as of Q3 2020.

Based on PEAK6 Investments's 13F filing for Q3 2020, filed 13 Nov 2020.